Accessibility Menu
 
Arrow-Thin-Down
S&P 500
7,230.12
+0.3%
+21.11
Arrow-Thin-Down
DJI
49,499.27
-0.3%
-152.87
Arrow-Thin-Down
NASDAQ
25,114.44
+0.9%
+222.13
Arrow-Thin-Down
Bitcoin
$80,061.00
+2.5%
+$1,940.49
Arrow-Thin-Down
AAPL
$280.19
+3.3%
+$8.84
Arrow-Thin-Down
AMZN
$268.36
+1.2%
+$3.30
Arrow-Thin-Down
GOOG
$382.96
+0.3%
+$1.02
Arrow-Thin-Down
META
$608.57
-0.5%
-$3.34
Arrow-Thin-Down
MSFT
$414.40
+1.6%
+$6.62
Arrow-Thin-Down
NVDA
$198.61
-0.5%
-$0.96
Arrow-Thin-Down
TSLA
$390.97
+2.4%
+$9.34
Most Active StocksDaily Stock GainersDaily Stock Losers
Biohaven logo

Biohaven

(NYSE) BHVN

Current Price$9.63
Market Cap$1.45B
Since IPO (2022)+32%
5 YearN/A
1 Year-57%
1 Month+0%

Biohaven Financials at a Glance

Market Cap

$1.45B

Revenue (TTM)

$0.00

Net Income (TTM)

$738.82M

EPS (TTM)

$-6.96

P/E Ratio

-1.38

Dividend

$0.00

Beta (Volatility)

1.51 (High)

Price

$9.63

Volume

1,280,331

Open

$9.70

Previous Close

$9.63

Daily Range

$9.52 - $9.89

52-Week Range

$7.48 - $23.37

BHVN News

Two people participating in a telehealth session

Why Biohaven Stock Crushed it on Monday

Eric VolkmanApr 13, 2026
BuyAlert-Blue.png

Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential

Jonathan PoncianoMar 23, 2026
BuyAlert-Purple.png

This $8.9 Million Buy Targets a Stock Down 68% With $322 Million in Cash

Jonathan PoncianoMar 21, 2026
BuyAlert-Green.png

Biohaven's Chief Accounting Officer Scooped Up 17,000 Shares. Is the Stock a Buy?

Robert IzquierdoNov 19, 2025
Person checking medicine on a shelf in a pharmacy

Why Biohaven Stock Zoomed More Than 6% Higher Today

Eric VolkmanAug 22, 2025
Person in a lab gazing into a microscope

Why Biohaven Stock Dove by Nearly 20% on Thursday

Eric VolkmanMay 15, 2025
Biotech 2025

Why BioHaven Stock Is Soaring Today

Johnny RiceApr 28, 2025
Two people in white lab coats looking at a computer display

Why Biohaven Stock Plummeted by More Than 15% Today

Eric VolkmanApr 25, 2025
Page 1

BHVN: Motley Fool Moneyball Superscore

43

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Biohaven

Industry

Biotechnology

Sector

Health Care

Employees

274

CEO

Vladimir Coric, MD

Website

www.biohaven.com

Headquarters

New Haven, CT 06510, US

BHVN Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-311%

Return on Capital

-2%

Return on Assets

-2%

Earnings Yield

-72.46%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.45B

Shares Outstanding

150.42M

Volume

1.28M

Avg. Volume

2.19M

Financials (TTM)

Gross Profit

$4.14M

Operating Income

$745.38M

EBITDA

$727.46M

Operating Cash Flow

$609.44M

Capital Expenditure

$715.00K

Free Cash Flow

$610.15M

Cash & ST Invst.

$319.14M

Total Debt

$278.86M

Biohaven Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

$960.00K

N/A

Gross Margin

0.00%

N/A

Market Cap

$1.45B

N/A

Market Cap/Employee

$5.66M

N/A

Employees

256

N/A

Net Income

$145.56M

+22.1%

EBITDA

$142.63M

+23.9%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$40.28M

-91.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$0.00

N/A

Long Term Debt

$278.86M

+750.6%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.64%

N/A

Return on Invested Capital

-2.22%

N/A

Free Cash Flow

$130.67M

+23.5%

Operating Cash Flow

$130.66M

+23.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
IMCRImmunocore Holdings plc
$28.16+0.90%
ABCLAbCellera Biologics Inc.
$4.43+6.75%
NTLAIntellia Therapeutics, Inc.
$13.26-1.63%
SIONSionna Therapeutics, Inc.
$39.15+1.16%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$99.62+0.05%
NOKNokia
$13.30+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.07+0.05%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.70+0.01%

Questions About BHVN

What is the current price of Biohaven?

Biohaven is trading at $9.63 per share.

What is the 52-week range for Biohaven?

Over the past 52 weeks, Biohaven has traded between $7.48 and $23.37.

How much debt does Biohaven have?

As of the most recent reporting period, Biohaven reported total debt of $284.61M.

How much cash does Biohaven have on hand?

Biohaven reported $230.48M in cash and cash equivalents in its most recent financial results.

What is Biohaven’s dividend yield?

Biohaven does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services